Metrics other than potency reveal systematic variation in responses to cancer drugs - Dataset (ID:20120)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10344-1 | Olomoucine II | LSM-6356 | 10067756 | ||
10035-2 | Sigma A6730 | KIN001-102; AKT inhibitor VIII; Akt1/2 kinase inhibitor | LSM-1035 | 10196499 | |
10283-1 | XRP44X | AG-G-87906 | LSM-4298 | 10339779 | |
10276-1 | TCS 2312 | LSM-6362 | 11258443 | ||
10268-1 | Nutlin 3a | LSM-6351 | 11433190 | ||
10142-2 | Trametinib | GSK-1120212; GSK1120212; GSK1120212B; JTP-74057 | LSM-1143 | 11707110 | |
10098-2 | Gefitinib | ZD1839; Iressa | LSM-1098 | 123631 | |
10230-2 | Lestaurtinib | CEP-701 | LSM-1231 | 126565 | |
10026-3 | PD173074 | LSM-1026 | 1401 | ||
10247-1 | Docetaxel | Taxotere | LSM-6360 | 148124 | |
10277-1 | Temsirolimus | LSM-4295 | 148191 | ||
10236-1 | 17-AAG | Tanespimycin | LSM-43239 | 151069 | |
10013-3 | GSK461364 | GSK461364A | LSM-1013 | 15983966 | |
10265-1 | Pevonedistat | MLN 4924; MLN-4924; MLN4924 | LSM-6263 | 16720766 | |
10097-3 | Erlotinib | OSI-774 | LSM-1097 | 176870 | |
10237-1 | 5-DFUR | 5-FdUR; Doxifluridine | LSM-6359 | 18343 | |
10223-2 | AG1478 | Tyrphostin | LSM-1224 | 2051 | |
10261-1 | Ixabepilone | Azaepothilone B; Ixempra | LSM-43293 | 216344 | |
10146-2 | Omipalisib | GSK2126458; GSK2126458A | LSM-1147 | 25167777 | |
10255-1 | GSK1838705A | LSM-4276 | 25182616 | ||
10175-3 | Sunitinib | Sutent; SU11248 | LSM-42800 | 3086686 | |
10248-1 | Doxorubicin | Adriamycin | LSM-4062 | 31703 | |
10238-1 | 5-FU | Fluorouracil | LSM-4261 | 3385 | |
10346-1 | Valproic acid | Depakine | LSM-4620 | 3549980 | |
10250-1 | Etoposide | LSM-6348 | 36462 |